Pembrolizumab-induced dermatomyositis in a patient with metastatic melanoma

We report herein the case of an 83-year-old patient who presented a dermatomyositis under treatment with pembrolizumab.

Source: European Journal of Cancer - October 12, 2018 Category: Cancer & Oncology Authors: Mathilde Berger, Anne-Lise Legeay, Sabrine Souci, Nathalie Streichenberger, Luc Thomas, St éphane Dalle Tags: Letter to the Editor Source Type: research